|
시장보고서
상품코드
2075160
플라스미드 DNA 제조 시장 : 제품 유형별, 등급별, 용도별, 제조 유형별, 개발 단계별, 지역별 규모, 점유율, 전망 및 기회 분석(2025-2032년)Plasmid DNA Manufacturing Market, By Product Type, By Grade, By Application, By Manufacturing Type, By Development Phase, By Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
플라스미드 DNA 제조 시장 규모는 2026년에 16억 6,010만 달러로 추정되고 있으며, 2033년까지 69억 5,110만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 22.7%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 16억 6,010만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 22.70% | 2033년 시장 규모 예측 : | 69억 5,110만 달러 |
세균의 세포질 내에 존재하며, 세균의 염색체와는 독립적으로 복제되는 고리형 이중가닥 DNA를 플라스미드 DNA라고 합니다. 플라스미드란 세포 내에 존재하는 작은 염색체 외 DNA 분자로, 염색체 DNA와는 물리적으로 분리되어 있으며 독립적으로 복제될 수 있습니다. 플라스미드는 세균 내에서 작은 고리 모양의 이중가닥 DNA 분자로 가장 흔히 발견됩니다. 그러나 플라스미드는 고세균이나 진핵생물에서도 존재할 수 있습니다.
각 플라스미드에는 각각 고유한 복제 기점이 있습니다. 이는 숙주가 되는 세균에 의해 복제(복사)되도록 보장하는 DNA 영역입니다. 따라서 플라스미드는 세균의 염색체와 독립적으로 자가 복제할 수 있으며, 세균 세포 내에는 경우에 따라 수백 개에 달하는 플라스미드 사본이 존재할 수도 있습니다.
시장 역학
적절한 제품 및 생산량 요건을 충족하기 위해 기존 제조 기술 분야의 혁신에 대한 수요가 증가하고 있으며, 이는 시장의 주요 기업에게 막대한 성장 기회를 가져다줄 것으로 예상됩니다. 예를 들어 2021년 3월, 게인즈빌에 본사를 둔 생명공학 기업인 Evolugate, LLC는 자사의 독자적인 기술을 활용하여 플라스미드 DNA 제조의 처리량을 향상시킬 수 있음을 입증했습니다.
시장 주요 기업의 제품 포트폴리오 확대를 목적으로 한 인수합병 등 비유기적 성장 전략의 증가가 예측 기간 중 시장 성장을 촉진할 것으로 전망됩니다. 예를 들어 2022년 1월, Aldevron사는 세포 및 유전자 치료 분야에서 사용되는 혁신적이고 독자적인 플라스미드 구축체 및 제조 솔루션을 개발하는 Nature Technology Corporation(NTC)의 인수를 발표했습니다. NTC의 핵산 기반 기술에는 플라스미드 및 생물제제의 안전성과 성능을 향상시키는 독자적인 벡터 구축체인 'Nanoplasmid'가 포함되어 있습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 플라스미드 DNA 제조 시장의 주요 기업 개요을 소개하고 있습니다. 본 조사에서 다룬 주요 기업 : Cobra Biologics and Pharmaceutical Services(Charles River Laboratories), VGXI, Inc., Aldevron(Danaher), Kaneka Corporation, Nature Technology, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, LakePharma, Inc., MeiraGTx Limited, Eurofins Genomics, Vigene Biosciences, Luminous BioSciences(LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio(AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc., Altogen Biosystems, Puresyn, Inc., Cepham Life Sciences, Catalent, Inc., Biomiga, Waisman Biomanufacturing.
- 이 보고서에서 도출된 인사이트는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 충분한 정보를 바탕으로 의사결정을 내리는 데 도움이 될 것입니다.
- 이 '세계의 플라스미드 DNA 제조 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 플라스미드 DNA 제조 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 플라스미드 DNA 제조 시장 : 제품 유형별, 2021-2033년
제5장 세계의 플라스미드 DNA 제조 시장 : 등급별, 2021-2033년
제6장 세계의 플라스미드 DNA 제조 시장 : 용도별, 2021-2033년
제7장 세계의 플라스미드 DNA 제조 시장 : 제조 유형별, 2021-2033년
제8장 세계의 플라스미드 DNA 제조 시장 : 개발 단계별, 2021-2033년
제9장 세계의 플라스미드 DNA 제조 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSA 26.07.07Plasmid DNA Manufacturing Market is estimated to be valued at USD 1,660.1 Mn in 2026 and is expected to reach USD 6,951.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 22.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,660.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 22.70% | 2033 Value Projection: | USD 6,951.1 Mn |
Circular double-stranded DNA present in the cytoplasm of a bacteria that replicate independently from the bacterial chromosome is called a plasmid DNA. Plasmids are small extra chromosomal DNA molecules within cells that are physically separated from the chromosomal DNA and capable of independent replication. They are most commonly found as small circular double-stranded DNA molecules in bacteria. However, plasmids can be present in archaea and eukaryotes.
Each plasmid has its own origin of replication. This is a stretch of DNA that ensures it is replicated (copied) by the host bacteria. Because of this, plasmids can copy themselves independently of the bacterial chromosome, and there can be many, possibly hundreds, copies of the plasmid within the bacterial cell.
Market Dynamics
Demand for innovation in existing manufacturing technologies, in order to meet the requirement of appropriate products and its volume is expected to provide immense growth opportunities for key players in the market. For instance, in March 2021, Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing.
The increasing inorganic strategies such as acquisition by the key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, In January 2022, Aldevron announced the acquisition of Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC's nucleic acid-based technologies include Nanoplasmid, a proprietary vector construct that improves the safety and performance of plasmids and biologics.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global plasmid DNA manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Cobra Biologics and Pharmaceutical Services (Charles River Laboratories), VGXI, Inc., Aldevron (Danaher), Kaneka Corporation, Nature Technology, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, LakePharma, Inc., MeiraGTx Limited, Eurofins Genomics, Vigene Biosciences, Luminous BioSciences (LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc., Altogen Biosystems, Puresyn, Inc., Cepham Life Sciences, Catalent, Inc., Biomiga, Waisman Biomanufacturing
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global plasmid DNA manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasmid DNA manufacturing market
Detailed Segmentation:
- Global Plasmid DNA Manufacturing Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Viral Vectors
- Retroviral
- Adenoviral
- Lentiviral
- Adeno Associates
- Others
- Plasmid DNA
- mRNA
- Others
- Non-viral
- Lipid/Polymer
- Electroporation
- Nanoparticles
- Others
- Global Plasmid DNA Manufacturing Market, By Grade (Revenue, USD Mn, 2021 - 2033)
- GMP Grade
- R&D Grade
- Clinical Grade
- Global Plasmid DNA Manufacturing Market By Application (Revenue, USD Mn, 2021 - 2033)
- DNA Vaccines
- Gene Therapy
- Immunotherapy
- RNA Vaccines
- Others
- Global Plasmid DNA Manufacturing Market By Manufacturing Type (Revenue, USD Mn, 2021 - 2033)
- Outsourcing
- In-house Manufacturing
- Global Plasmid DNA Manufacturing Market By Development Phase (Revenue, USD Mn, 2021 - 2033)
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Global Plasmid DNA Manufacturing Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Country:
- India
- China
- Japan
- Australia
- ASEAN
- South Korea
- Rest of Middle East
- By Country:
- Middle East
- By Country:
- GCC
- Israel
- Japan
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- Cobra Biologics and Pharmaceutical Services (Charles River Laboratories)*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- VGXI, Inc.
- Aldevron (Danaher)
- Kaneka Corporation
- Nature Technology
- PlasmidFactory GmbH & Co. KG
- Cell and Gene Therapy Catapult
- LakePharma, Inc.
- MeiraGTx Limited
- Eurofins Genomics
- Vigene Biosciences
- Luminous BioSciences (LBS), LLC
- GenScript
- GENEWIZ
- Creative Biogene
- Akron Biotech
- Biomay
- JAFRAL Ltd.
- WuXi Biologics
- GeneImmune Biotechnology Corp.
- Lonza
- Greenpak Biotech Ltd.
- Luina Bio (AcuraBio)
- Ajinomoto Bio-Pharma,
- Synbio Technologies, Genopis Inc.
- Altogen Biosystems, Puresyn, Inc.
- Cepham Life Sciences, Catalent, Inc.
- Biomiga
- Waisman Biomanufacturing
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Grade
- Market Snapshot, By Application
- Market Snapshot, By Manufacturing Type
- Market Snapshot, By Development Phase
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- PORTER's Analysis
- Pricing Analysis (2022)
- Guidelines Specific for the Development of Plasmid DNA Vaccines
- Genomic Titer
4. Global Plasmid DNA Manufacturing Market, By Product Type, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Viral Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Retroviral
- Adenoviral
- Lentiviral
- Adeno Associates
- Others
- Plasmid DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- mRNA
- Others
- Non-viral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Lipid/Polymer
- Electroporation
- Nanoparticles
- Others
5. Global Plasmid DNA Manufacturing Market, By Grade, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- GMP Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- R&D Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Clinical Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Plasmid DNA Manufacturing Market, By Application, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- DNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- RNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Plasmid DNA Manufacturing Market, By Manufacturing Type, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- Outsourcing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- In-house Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
8. Global Plasmid DNA Manufacturing Market, By Development Phase, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- Pre-Clinical Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Clinical Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Marketed Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
9. Global Plasmid DNA Manufacturing Market, By Region, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Cobra Biologics and Pharmaceutical Services (Charles River Laboratories).*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- VGXI, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aldevron (Danaher)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kaneka Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nature Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PlasmidFactory GmbH & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cell and Gene Therapy Catapult
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LakePharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MeiraGTx Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eurofins Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vigene Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Luminous BioSciences (LBS), LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GENEWIZ
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative Biogene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Akron Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomay
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- JAFRAL Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- WuXi Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GeneImmune Biotechnology Corp.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Greenpak Biotech Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Luina Bio (AcuraBio)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ajinomoto Bio-Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Synbio Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genopis Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Altogen Biosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Puresyn, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cepham Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Catalent, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomiga
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Waisman Biomanufacturing
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
11. Section
- Research Methodology
- About Us
